A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns

Nature Genetics
Nanda A SinghM Leppert

Abstract

Idiopathic generalized epilepsies account for about 40% of epilepsy up to age 40 and commonly have a genetic basis. One type is benign familial neonatal convulsions (BFNC), a dominantly inherited disorder of newborns. We have identified a sub-microscopic deletion of chromosome 20q13.3 that co-segregates with seizures in a BFNC family. Characterization of cDNAs spanning the deleted region identified one encoding a novel voltage-gated potassium channel, KCNQ2, which belongs to a new KQT-like class of potassium channels. Five other BFNC probands were shown to have KCNQ2 mutations, including two transmembrane missense mutations, two frameshifts and one splice-site mutation. This finding in BFNC provides additional evidence that defects in potassium channels are involved in the mammalian epilepsy phenotype.

References

Oct 5, 1990·Journal of Molecular Biology·S F AltschulD J Lipman
Apr 1, 1994·Biophysical Journal·L HeginbothamR MacKinnon
Oct 1, 1993·Brain Pathology·M LeppertM Connolly
Jun 1, 1996·Current Opinion in Genetics & Development·M T Keating, M C Sanguinetti
Sep 1, 1996·Human Molecular Genetics·M W RussellL C Brody
Jan 10, 1997·The Journal of Biological Chemistry·R L NakamuraR F Gaber
Feb 4, 1997·Proceedings of the National Academy of Sciences of the United States of America·S SignoriniM Stoffel
Oct 31, 1996·DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes·M YokoyamaK Matsubara
Jan 1, 1997·Annual Review of Neuroscience·L Y Jan, Y N Jan
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·W P YangM A Blanar
Mar 1, 1997·Human Molecular Genetics·M GuipponiA Malafosse
Jun 1, 1997·Neuropharmacology·M C Sanguinetti, P S Spector
Jan 1, 1995·Epilepsia·B S Meldrum

❮ Previous
Next ❯

Citations

Dec 7, 2000·Mental Retardation and Developmental Disabilities Research Reviews·E M Mizrahi, R R Clancy
Dec 7, 2000·Mental Retardation and Developmental Disabilities Research Reviews·C E Stafstrom, B L Tempel
Sep 11, 1999·Annals of Neurology·H LercheO K Steinlein
Oct 8, 1999·Annals of Neurology·A PeifferM Leppert
Jun 1, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·K P BhatiaL J Ptácek
Jun 21, 2001·Annals of Neurology·X F Yang, S M Rothman
Sep 5, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Sian D SpaceyNicholas W Wood
Apr 24, 2001·Muscle & Nerve·R LiguoriP Montagna
Jul 2, 2003·Neurotoxicity Research·Antonio Gil-Nagel
Jan 24, 2007·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Melodie R WinawerAbraham A Palmer
Nov 13, 2012·Journal of Neurology·Snezana Maljevic, Holger Lerche
Apr 20, 2010·Pflügers Archiv : European journal of physiology·Snezana MaljevicHolger Lerche
Jul 27, 2007·Cell Biochemistry and Biophysics·Leonardo HernandezFederico Sesti
Mar 18, 2004·Bioorganic & Medicinal Chemistry Letters·Piyasena HewawasamSteven I Dworetzky
Nov 5, 2003·Experimental Neurology·Robert L MacdonaldHuajun Feng
Jan 3, 2007·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Brian S Meldrum, Michael A Rogawski
Mar 31, 2007·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Sarah E HeronJohn C Mulley
Mar 31, 2007·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Sanjeev RajakulendranMichael G Hanna
Jan 1, 1999·Electroencephalography and Clinical Neurophysiology·K KobayashiT Hashimoto
Apr 20, 2000·European Journal of Pharmacology·O K Steinlein
Mar 14, 2002·European Journal of Pharmacology·Delphine S DupuisSøren P Olesen
Dec 31, 2002·Neuropharmacology·Alan D Wickenden
Aug 26, 2000·Progress in Biophysics and Molecular Biology·B S Brown, S P Yu
Jul 13, 2001·Pharmacology & Therapeutics·J Robbins
Aug 23, 2002·Pharmacology & Therapeutics·Alan Wickenden
Nov 3, 2001·Brain Research. Brain Research Reviews·B MoulardD Bertrand
Jun 6, 2000·Trends in Pharmacological Sciences·M C Sanguinetti
Aug 14, 2003·Trends in Pharmacological Sciences·Ingrid E Scheffer, Samuel F Berkovic
Sep 3, 2002·Neuroscience Research·Sunao KanekoShinichi Hirose
Oct 19, 2000·Brain Research. Molecular Brain Research·F Jow, K Wang
May 17, 2002·Brain & Development·Shinichi HiroseAkihisa Mitsudome
Jul 10, 2003·Brain & Development·Shinichi HiroseAkihisa Mitsudome
May 8, 2004·Brain & Development·Ortrud K Steinlein
May 19, 2001·Neurologic Clinics·E M Mizrah
Jun 23, 2000·Epilepsy Research·K MizunoS Kaneko

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.